# Lexeo Therapeutics (LXEO) — Earnings

LXEO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lxeo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.60 |
| EPS estimate | −$0.68 |
| EPS surprise | +11.69% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1907108/000095017025108427/lxeo-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.68 | −$0.60 | 11.69% | — | — |
| Q1 2025 | May 12, 2025 | −$0.78 | −$0.99 | -26.39% | — | — |
| Q4 2024 | Mar 24, 2025 | −$0.81 | −$0.78 | 3.36% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.68 | −$0.89 | -31.19% | — | — |
| Q2 2024 | Aug 12, 2024 | −$0.69 | −$0.64 | 7.43% | — | — |
| Q4 2023 | Mar 11, 2024 | −$0.70 | −$0.86 | -23.44% | — | — |

## Frequently Asked Questions

### When did Lexeo Therapeutics (LXEO) last report earnings?

Lexeo Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did LXEO beat earnings estimates?

Yes. Lexeo Therapeutics reported EPS of −$0.60 for Q2 2025 against a −$0.68 estimate — a 11.69% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).